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Future avenues
Further validation of PCLS is necessary, by directly comparing in vivo and ex vivo studies, preferably in the same experimental setting, to show the predictive power of PCLS for liver pathology and pharmacological intervention in vivo. 
Krumdieck slicer
To
, NASH, fibrosis, and hepatocellular carcinoma. The in vitro models currently utilized in liver research cannot predict or mimic the complex cellular interactions that occur in vivo. Thus in isolated primary cells or cell lines, dedifferentiation rapidly occurs, partly due to the loss of the natural environment, including cues from the extracellular matrix and neighbouring or migratory cells. On the other hand, utilization of in vivo animal experiments has other shortcomings. In vivo studies (1) require large numbers of animals for extended time periods, raising both ethical and financial issues, (2) suffer from interindividual variation, and (3) also have limited implications for human disease, not only due to the notorious lack of appropriate models, but also to relevant species differences in molecular pathogenesis [1] . Therefore, ex vivo models are needed that (1) resemble the in vivo environment, (2) are reproducible, (3) are low cost and reduce the requirement of live animals, and (4) permit the testing in complex human systems. Precision-cut tissue slices (PCLS) represent an ex vivo tissue culture technique that mimics the multicellular characteristics of organs in vivo.
Ex vivo liver research started with the pioneering work of Warburg and Krebs in the early twenties [2] . They used liver slices that were prepared manually with limited reproducibility and viability. After a decline in favour of in vitro techniques and of another ex vivo (liver perfusion) model, the principle was resurrected in the nineties, when the Krumdieck slicer was developed, enabling the production of reproducible and viable tissue slices. In addition, different incubation systems were developed to successfully culture PCLS [3, 4] , maintaining viability of hepatocytes, Kupffer, endothelial, and hepatic stellate cells [1, 5] . Drug transport studies in PCLS clearly showed that besides small molecules, such as digoxin, also larger molecules, like modified human serum albumin, can enter PCLS [6] . De Graaf et al. [7] published a detailed description of the preparation and culture of PCLS (see Figure) . Another emerging ex vivo technique is the decellularized liver extracellular matrix [8] . Compared to the multicellular PCLS that contain a native extracellular matrix (ECM), it uses an altered ECM and is a complex technique. Moreover, to date only single cell types have been used to repopulate these ECM scaffolds.
Current use
PCLS have been used extensively to examine drug metabolism and toxicity. Several studies showed the relevance of PCLS in predicting drug metabolism in the human body [1] . Extrapolations from the results obtained in PCLS to the in vivo condition have been successfully established for metabolic clearance, metabolism, and toxicity of several drugs (Table 1 ). This can be explained by a relatively stable expression of transporters and enzymes that are involved in drug metabolism during culture of PCLS [9] . However, others found decreased expression of certain iso-enzymes and drug transporters (Table 1) , which was attributed to the lack of endogenous or exogenous inductive stimuli in PCLS culture medium [9] , a problem which needs to be addressed in future studies.
Taking advantage of the multicellular composition of PCLS, different stages of (human) liver fibrosis have been successfully investigated, not only to study mechanisms of fibrogenesis, but also to assess the efficacy of anti-fibrotic agents, using, e.g., the downregulation of procollagen type I gene and protein expression as readout [5, 10] .
Studies on hepatitis B and C are impeded by their limitation to cell culture and complex in vivo disease models. A recent report has demonstrated the feasibility of hepatitis C studies in human PCLS [11] . Furthermore, PCLS are now also used in cancer and metabolic liver disease research [12, 13] .
Future avenues
Further validation of PCLS is necessary, by directly comparing in vivo and ex vivo studies, preferably in the same experimental setting, to show the predictive power of PCLS for liver pathology and pharmacological intervention in vivo.
Furthermore, PCLS could become an important tool for a personalized medicine. Thus PCLS can be prepared from resected tumor material [12] , to determine the most effective cytostatic drug or drug combination ex vivo. Precision-cut slices can also be prepared and maintained from other organs [3] enabling serial multi-organ incubations, allowing, e.g., studies on the gut-liver axis [14] . Human PCLS can be cultured for up to 7 days [15] , but some functions, such as full metabolic capacity, are maintained only for 3 days (Table   1 ) [15] . Therefore, PCLS culture conditions should be further optimized to better model the liver in vivo over prolonged periods of time. Using exogenous and endogenous inductive stimuli and adding circulating components, e.g., lymphocytes, innate immune cells, chemokines or hormones, could improve the reliability of PCLS. Further progress is also envisaged by perifusing PCLS in a microfluidic system [14] . PCLS are not yet an established tool in drug discovery, likely due to the absence of PCLS cryo-banks that would facilitate material exchange and standardization. Such cryopreservation appears indeed feasible [16] .
Conclusion
In summary, PCLS are a unique and promising ex vivo system, located in-between experimental and human studies. This technology promises to develop into a pivotal tool to assess hepatic drug metabolism and toxicology, and to test pharmacological agents in various liver diseases. © 2013
European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
